THERAPEUTICS
Glycaemic control was not affected by self-monitoring of blood glucose in type 2 diabetes
| The first 150 words of the full text of this article appear below. |
M J OKane
Dr M J OKane, Altnagelvin Hospital, Londonderry, Northern Ireland; maurice.okane@esterntrust.hscni.net
STUDY DESIGN
randomised controlled trial (Efficacy of Self Monitoring On glycaemic control in Newly diagnosed type 2 diabetes [ESMON]).
unclear allocation concealment.*
blinded (laboratory staff).*
STUDY QUESTION
outpatient hospital diabetes clinics in Altnagelvin, Belfast City, Causeway, and Ulster, Northern Ireland.
184 patients <70 years of age (mean age 59 y, 60% men) with newly diagnosed type 2 diabetes. Exclusion criteria were secondary diabetes, previous self-monitoring of blood glucose (SMBG), use of insulin, major illness in the past 6 months, chronic kidney or liver disease, and alcohol misuse.
SMBG (n = 96) or no monitoring (n = 88). The SMBG group made 4 fasting and 4 postprandial capillary blood glucose measurements per week and were provided dietary and exercise suggestions for high readings. All patients attended a structured education programme.
changes in haemoglobin (Hb) A1c concentrations, scores on psychological indices (depression, anxiety,
University of Alberta, Edmonton, Alberta, Canada
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
